Global Pharmacogenomics (PGx) Market Insights, Forecast to 2028

Report ID: 1665195 | Published Date: Jan 2025 | No. of Page: 118 | Base Year: 2024 | Rating: 4.5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Pharmacogenomics (PGx) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Polymerase Chain Reaction (PCR)
        1.2.3 Microarray
        1.2.4 Sequencing
        1.2.5 Other
    1.3 Market by Application
        1.3.1 Global Pharmacogenomics (PGx) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Cardiovascular Diseases (CVD)
        1.3.3 Central Nervous System (CNS)
        1.3.4 Cancer/Oncology
        1.3.5 Infectious Diseases
        1.3.6 Other
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Pharmacogenomics (PGx) Market Perspective (2017-2028)
    2.2 Pharmacogenomics (PGx) Growth Trends by Region
        2.2.1 Pharmacogenomics (PGx) Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Pharmacogenomics (PGx) Historic Market Size by Region (2017-2022)
        2.2.3 Pharmacogenomics (PGx) Forecasted Market Size by Region (2023-2028)
    2.3 Pharmacogenomics (PGx) Market Dynamics
        2.3.1 Pharmacogenomics (PGx) Industry Trends
        2.3.2 Pharmacogenomics (PGx) Market Drivers
        2.3.3 Pharmacogenomics (PGx) Market Challenges
        2.3.4 Pharmacogenomics (PGx) Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Pharmacogenomics (PGx) Players by Revenue
        3.1.1 Global Top Pharmacogenomics (PGx) Players by Revenue (2017-2022)
        3.1.2 Global Pharmacogenomics (PGx) Revenue Market Share by Players (2017-2022)
    3.2 Global Pharmacogenomics (PGx) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Pharmacogenomics (PGx) Revenue
    3.4 Global Pharmacogenomics (PGx) Market Concentration Ratio
        3.4.1 Global Pharmacogenomics (PGx) Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Pharmacogenomics (PGx) Revenue in 2021
    3.5 Pharmacogenomics (PGx) Key Players Head office and Area Served
    3.6 Key Players Pharmacogenomics (PGx) Product Solution and Service
    3.7 Date of Enter into Pharmacogenomics (PGx) Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Pharmacogenomics (PGx) Breakdown Data by Type
    4.1 Global Pharmacogenomics (PGx) Historic Market Size by Type (2017-2022)
    4.2 Global Pharmacogenomics (PGx) Forecasted Market Size by Type (2023-2028)
5 Pharmacogenomics (PGx) Breakdown Data by Application
    5.1 Global Pharmacogenomics (PGx) Historic Market Size by Application (2017-2022)
    5.2 Global Pharmacogenomics (PGx) Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Pharmacogenomics (PGx) Market Size (2017-2028)
    6.2 North America Pharmacogenomics (PGx) Market Size by Type
        6.2.1 North America Pharmacogenomics (PGx) Market Size by Type (2017-2022)
        6.2.2 North America Pharmacogenomics (PGx) Market Size by Type (2023-2028)
        6.2.3 North America Pharmacogenomics (PGx) Market Share by Type (2017-2028)
    6.3 North America Pharmacogenomics (PGx) Market Size by Application
        6.3.1 North America Pharmacogenomics (PGx) Market Size by Application (2017-2022)
        6.3.2 North America Pharmacogenomics (PGx) Market Size by Application (2023-2028)
        6.3.3 North America Pharmacogenomics (PGx) Market Share by Application (2017-2028)
    6.4 North America Pharmacogenomics (PGx) Market Size by Country
        6.4.1 North America Pharmacogenomics (PGx) Market Size by Country (2017-2022)
        6.4.2 North America Pharmacogenomics (PGx) Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Pharmacogenomics (PGx) Market Size (2017-2028)
    7.2 Europe Pharmacogenomics (PGx) Market Size by Type
        7.2.1 Europe Pharmacogenomics (PGx) Market Size by Type (2017-2022)
        7.2.2 Europe Pharmacogenomics (PGx) Market Size by Type (2023-2028)
        7.2.3 Europe Pharmacogenomics (PGx) Market Share by Type (2017-2028)
    7.3 Europe Pharmacogenomics (PGx) Market Size by Application
        7.3.1 Europe Pharmacogenomics (PGx) Market Size by Application (2017-2022)
        7.3.2 Europe Pharmacogenomics (PGx) Market Size by Application (2023-2028)
        7.3.3 Europe Pharmacogenomics (PGx) Market Share by Application (2017-2028)
    7.4 Europe Pharmacogenomics (PGx) Market Size by Country
        7.4.1 Europe Pharmacogenomics (PGx) Market Size by Country (2017-2022)
        7.4.2 Europe Pharmacogenomics (PGx) Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Pharmacogenomics (PGx) Market Size (2017-2028)
    8.2 Asia-Pacific Pharmacogenomics (PGx) Market Size by Type
        8.2.1 Asia-Pacific Pharmacogenomics (PGx) Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Pharmacogenomics (PGx) Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Pharmacogenomics (PGx) Market Share by Type (2017-2028)
    8.3 Asia-Pacific Pharmacogenomics (PGx) Market Size by Application
        8.3.1 Asia-Pacific Pharmacogenomics (PGx) Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Pharmacogenomics (PGx) Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Pharmacogenomics (PGx) Market Share by Application (2017-2028)
    8.4 Asia-Pacific Pharmacogenomics (PGx) Market Size by Region
        8.4.1 Asia-Pacific Pharmacogenomics (PGx) Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Pharmacogenomics (PGx) Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Pharmacogenomics (PGx) Market Size (2017-2028)
    9.2 Latin America Pharmacogenomics (PGx) Market Size by Type
        9.2.1 Latin America Pharmacogenomics (PGx) Market Size by Type (2017-2022)
        9.2.2 Latin America Pharmacogenomics (PGx) Market Size by Type (2023-2028)
        9.2.3 Latin America Pharmacogenomics (PGx) Market Share by Type (2017-2028)
    9.3 Latin America Pharmacogenomics (PGx) Market Size by Application
        9.3.1 Latin America Pharmacogenomics (PGx) Market Size by Application (2017-2022)
        9.3.2 Latin America Pharmacogenomics (PGx) Market Size by Application (2023-2028)
        9.3.3 Latin America Pharmacogenomics (PGx) Market Share by Application (2017-2028)
    9.4 Latin America Pharmacogenomics (PGx) Market Size by Country
        9.4.1 Latin America Pharmacogenomics (PGx) Market Size by Country (2017-2022)
        9.4.2 Latin America Pharmacogenomics (PGx) Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Pharmacogenomics (PGx) Market Size (2017-2028)
    10.2 Middle East & Africa Pharmacogenomics (PGx) Market Size by Type
        10.2.1 Middle East & Africa Pharmacogenomics (PGx) Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Pharmacogenomics (PGx) Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Pharmacogenomics (PGx) Market Share by Type (2017-2028)
    10.3 Middle East & Africa Pharmacogenomics (PGx) Market Size by Application
        10.3.1 Middle East & Africa Pharmacogenomics (PGx) Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Pharmacogenomics (PGx) Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Pharmacogenomics (PGx) Market Share by Application (2017-2028)
    10.4 Middle East & Africa Pharmacogenomics (PGx) Market Size by Country
        10.4.1 Middle East & Africa Pharmacogenomics (PGx) Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Pharmacogenomics (PGx) Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Abbott Laboratories
        11.1.1 Abbott Laboratories Company Details
        11.1.2 Abbott Laboratories Business Overview
        11.1.3 Abbott Laboratories Pharmacogenomics (PGx) Introduction
        11.1.4 Abbott Laboratories Revenue in Pharmacogenomics (PGx) Business (2017-2022)
        11.1.5 Abbott Laboratories Recent Developments
    11.2 Affymetrix, Inc.
        11.2.1 Affymetrix, Inc. Company Details
        11.2.2 Affymetrix, Inc. Business Overview
        11.2.3 Affymetrix, Inc. Pharmacogenomics (PGx) Introduction
        11.2.4 Affymetrix, Inc. Revenue in Pharmacogenomics (PGx) Business (2017-2022)
        11.2.5 Affymetrix, Inc. Recent Developments
    11.3 Assurex Health, Inc
        11.3.1 Assurex Health, Inc Company Details
        11.3.2 Assurex Health, Inc Business Overview
        11.3.3 Assurex Health, Inc Pharmacogenomics (PGx) Introduction
        11.3.4 Assurex Health, Inc Revenue in Pharmacogenomics (PGx) Business (2017-2022)
        11.3.5 Assurex Health, Inc Recent Developments
    11.4 Astrazeneca
        11.4.1 Astrazeneca Company Details
        11.4.2 Astrazeneca Business Overview
        11.4.3 Astrazeneca Pharmacogenomics (PGx) Introduction
        11.4.4 Astrazeneca Revenue in Pharmacogenomics (PGx) Business (2017-2022)
        11.4.5 Astrazeneca Recent Developments
    11.5 GeneDX
        11.5.1 GeneDX Company Details
        11.5.2 GeneDX Business Overview
        11.5.3 GeneDX Pharmacogenomics (PGx) Introduction
        11.5.4 GeneDX Revenue in Pharmacogenomics (PGx) Business (2017-2022)
        11.5.5 GeneDX Recent Developments
    11.6 Illumina, Inc.
        11.6.1 Illumina, Inc. Company Details
        11.6.2 Illumina, Inc. Business Overview
        11.6.3 Illumina, Inc. Pharmacogenomics (PGx) Introduction
        11.6.4 Illumina, Inc. Revenue in Pharmacogenomics (PGx) Business (2017-2022)
        11.6.5 Illumina, Inc. Recent Developments
    11.7 Laboratory Corporation of America Holdings
        11.7.1 Laboratory Corporation of America Holdings Company Details
        11.7.2 Laboratory Corporation of America Holdings Business Overview
        11.7.3 Laboratory Corporation of America Holdings Pharmacogenomics (PGx) Introduction
        11.7.4 Laboratory Corporation of America Holdings Revenue in Pharmacogenomics (PGx) Business (2017-2022)
        11.7.5 Laboratory Corporation of America Holdings Recent Developments
    11.8 Myriad Genetics, Inc.
        11.8.1 Myriad Genetics, Inc. Company Details
        11.8.2 Myriad Genetics, Inc. Business Overview
        11.8.3 Myriad Genetics, Inc. Pharmacogenomics (PGx) Introduction
        11.8.4 Myriad Genetics, Inc. Revenue in Pharmacogenomics (PGx) Business (2017-2022)
        11.8.5 Myriad Genetics, Inc. Recent Developments
    11.9 Pathway Genomics
        11.9.1 Pathway Genomics Company Details
        11.9.2 Pathway Genomics Business Overview
        11.9.3 Pathway Genomics Pharmacogenomics (PGx) Introduction
        11.9.4 Pathway Genomics Revenue in Pharmacogenomics (PGx) Business (2017-2022)
        11.9.5 Pathway Genomics Recent Developments
    11.10 Pfizer, Inc
        11.10.1 Pfizer, Inc Company Details
        11.10.2 Pfizer, Inc Business Overview
        11.10.3 Pfizer, Inc Pharmacogenomics (PGx) Introduction
        11.10.4 Pfizer, Inc Revenue in Pharmacogenomics (PGx) Business (2017-2022)
        11.10.5 Pfizer, Inc Recent Developments
    11.11 Qiagen, Inc.
        11.11.1 Qiagen, Inc. Company Details
        11.11.2 Qiagen, Inc. Business Overview
        11.11.3 Qiagen, Inc. Pharmacogenomics (PGx) Introduction
        11.11.4 Qiagen, Inc. Revenue in Pharmacogenomics (PGx) Business (2017-2022)
        11.11.5 Qiagen, Inc. Recent Developments
    11.12 Rocheg
        11.12.1 Rocheg Company Details
        11.12.2 Rocheg Business Overview
        11.12.3 Rocheg Pharmacogenomics (PGx) Introduction
        11.12.4 Rocheg Revenue in Pharmacogenomics (PGx) Business (2017-2022)
        11.12.5 Rocheg Recent Developments
    11.13 Teva Pharmaceutical Industries Ltd.
        11.13.1 Teva Pharmaceutical Industries Ltd. Company Details
        11.13.2 Teva Pharmaceutical Industries Ltd. Business Overview
        11.13.3 Teva Pharmaceutical Industries Ltd. Pharmacogenomics (PGx) Introduction
        11.13.4 Teva Pharmaceutical Industries Ltd. Revenue in Pharmacogenomics (PGx) Business (2017-2022)
        11.13.5 Teva Pharmaceutical Industries Ltd. Recent Developments
    11.14 Thermo Fisher Scientific
        11.14.1 Thermo Fisher Scientific Company Details
        11.14.2 Thermo Fisher Scientific Business Overview
        11.14.3 Thermo Fisher Scientific Pharmacogenomics (PGx) Introduction
        11.14.4 Thermo Fisher Scientific Revenue in Pharmacogenomics (PGx) Business (2017-2022)
        11.14.5 Thermo Fisher Scientific Recent Developments
    11.15 Transgenomic, Inc.
        11.15.1 Transgenomic, Inc. Company Details
        11.15.2 Transgenomic, Inc. Business Overview
        11.15.3 Transgenomic, Inc. Pharmacogenomics (PGx) Introduction
        11.15.4 Transgenomic, Inc. Revenue in Pharmacogenomics (PGx) Business (2017-2022)
        11.15.5 Transgenomic, Inc. Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer
List of Tables
    Table 1. Global Pharmacogenomics (PGx) Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Polymerase Chain Reaction (PCR)
    Table 3. Key Players of Microarray
    Table 4. Key Players of Sequencing
    Table 5. Key Players of Other
    Table 6. Global Pharmacogenomics (PGx) Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 7. Global Pharmacogenomics (PGx) Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Pharmacogenomics (PGx) Market Size by Region (2017-2022) & (US$ Million)
    Table 9. Global Pharmacogenomics (PGx) Market Share by Region (2017-2022)
    Table 10. Global Pharmacogenomics (PGx) Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 11. Global Pharmacogenomics (PGx) Market Share by Region (2023-2028)
    Table 12. Pharmacogenomics (PGx) Market Trends
    Table 13. Pharmacogenomics (PGx) Market Drivers
    Table 14. Pharmacogenomics (PGx) Market Challenges
    Table 15. Pharmacogenomics (PGx) Market Restraints
    Table 16. Global Pharmacogenomics (PGx) Revenue by Players (2017-2022) & (US$ Million)
    Table 17. Global Pharmacogenomics (PGx) Revenue Share by Players (2017-2022)
    Table 18. Global Top Pharmacogenomics (PGx) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmacogenomics (PGx) as of 2021)
    Table 19. Ranking of Global Top Pharmacogenomics (PGx) Companies by Revenue (US$ Million) in 2021
    Table 20. Global 5 Largest Players Market Share by Pharmacogenomics (PGx) Revenue (CR5 and HHI) & (2017-2022)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Pharmacogenomics (PGx) Product Solution and Service
    Table 23. Date of Enter into Pharmacogenomics (PGx) Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Pharmacogenomics (PGx) Market Size by Type (2017-2022) & (US$ Million)
    Table 26. Global Pharmacogenomics (PGx) Revenue Market Share by Type (2017-2022)
    Table 27. Global Pharmacogenomics (PGx) Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 28. Global Pharmacogenomics (PGx) Revenue Market Share by Type (2023-2028)
    Table 29. Global Pharmacogenomics (PGx) Market Size by Application (2017-2022) & (US$ Million)
    Table 30. Global Pharmacogenomics (PGx) Revenue Share by Application (2017-2022)
    Table 31. Global Pharmacogenomics (PGx) Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 32. Global Pharmacogenomics (PGx) Revenue Share by Application (2023-2028)
    Table 33. North America Pharmacogenomics (PGx) Market Size by Type (2017-2022) & (US$ Million)
    Table 34. North America Pharmacogenomics (PGx) Market Size by Type (2023-2028) & (US$ Million)
    Table 35. North America Pharmacogenomics (PGx) Market Size by Application (2017-2022) & (US$ Million)
    Table 36. North America Pharmacogenomics (PGx) Market Size by Application (2023-2028) & (US$ Million)
    Table 37. North America Pharmacogenomics (PGx) Market Size by Country (2017-2022) & (US$ Million)
    Table 38. North America Pharmacogenomics (PGx) Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Europe Pharmacogenomics (PGx) Market Size by Type (2017-2022) & (US$ Million)
    Table 40. Europe Pharmacogenomics (PGx) Market Size by Type (2023-2028) & (US$ Million)
    Table 41. Europe Pharmacogenomics (PGx) Market Size by Application (2017-2022) & (US$ Million)
    Table 42. Europe Pharmacogenomics (PGx) Market Size by Application (2023-2028) & (US$ Million)
    Table 43. Europe Pharmacogenomics (PGx) Market Size by Country (2017-2022) & (US$ Million)
    Table 44. Europe Pharmacogenomics (PGx) Market Size by Country (2023-2028) & (US$ Million)
    Table 45. Asia Pacific Pharmacogenomics (PGx) Market Size by Type (2017-2022) & (US$ Million)
    Table 46. Asia Pacific Pharmacogenomics (PGx) Market Size by Type (2023-2028) & (US$ Million)
    Table 47. Asia Pacific Pharmacogenomics (PGx) Market Size by Application (2017-2022) & (US$ Million)
    Table 48. Asia Pacific Pharmacogenomics (PGx) Market Size by Application (2023-2028) & (US$ Million)
    Table 49. Asia Pacific Pharmacogenomics (PGx) Market Size by Region (2017-2022) & (US$ Million)
    Table 50. Asia Pacific Pharmacogenomics (PGx) Market Size by Region (2023-2028) & (US$ Million)
    Table 51. Latin America Pharmacogenomics (PGx) Market Size by Type (2017-2022) & (US$ Million)
    Table 52. Latin America Pharmacogenomics (PGx) Market Size by Type (2023-2028) & (US$ Million)
    Table 53. Latin America Pharmacogenomics (PGx) Market Size by Application (2017-2022) & (US$ Million)
    Table 54. Latin America Pharmacogenomics (PGx) Market Size by Application (2023-2028) & (US$ Million)
    Table 55. Latin America Pharmacogenomics (PGx) Market Size by Country (2017-2022) & (US$ Million)
    Table 56. Latin America Pharmacogenomics (PGx) Market Size by Country (2023-2028) & (US$ Million)
    Table 57. Middle East and Africa Pharmacogenomics (PGx) Market Size by Type (2017-2022) & (US$ Million)
    Table 58. Middle East and Africa Pharmacogenomics (PGx) Market Size by Type (2023-2028) & (US$ Million)
    Table 59. Middle East and Africa Pharmacogenomics (PGx) Market Size by Application (2017-2022) & (US$ Million)
    Table 60. Middle East and Africa Pharmacogenomics (PGx) Market Size by Application (2023-2028) & (US$ Million)
    Table 61. Middle East and Africa Pharmacogenomics (PGx) Market Size by Country (2017-2022) & (US$ Million)
    Table 62. Middle East and Africa Pharmacogenomics (PGx) Market Size by Country (2023-2028) & (US$ Million)
    Table 63. Abbott Laboratories Company Details
    Table 64. Abbott Laboratories Business Overview
    Table 65. Abbott Laboratories Pharmacogenomics (PGx) Product
    Table 66. Abbott Laboratories Revenue in Pharmacogenomics (PGx) Business (2017-2022) & (US$ Million)
    Table 67. Abbott Laboratories Recent Developments
    Table 68. Affymetrix, Inc. Company Details
    Table 69. Affymetrix, Inc. Business Overview
    Table 70. Affymetrix, Inc. Pharmacogenomics (PGx) Product
    Table 71. Affymetrix, Inc. Revenue in Pharmacogenomics (PGx) Business (2017-2022) & (US$ Million)
    Table 72. Affymetrix, Inc. Recent Developments
    Table 73. Assurex Health, Inc Company Details
    Table 74. Assurex Health, Inc Business Overview
    Table 75. Assurex Health, Inc Pharmacogenomics (PGx) Product
    Table 76. Assurex Health, Inc Revenue in Pharmacogenomics (PGx) Business (2017-2022) & (US$ Million)
    Table 77. Assurex Health, Inc Recent Developments
    Table 78. Astrazeneca Company Details
    Table 79. Astrazeneca Business Overview
    Table 80. Astrazeneca Pharmacogenomics (PGx) Product
    Table 81. Astrazeneca Revenue in Pharmacogenomics (PGx) Business (2017-2022) & (US$ Million)
    Table 82. Astrazeneca Recent Developments
    Table 83. GeneDX Company Details
    Table 84. GeneDX Business Overview
    Table 85. GeneDX Pharmacogenomics (PGx) Product
    Table 86. GeneDX Revenue in Pharmacogenomics (PGx) Business (2017-2022) & (US$ Million)
    Table 87. GeneDX Recent Developments
    Table 88. Illumina, Inc. Company Details
    Table 89. Illumina, Inc. Business Overview
    Table 90. Illumina, Inc. Pharmacogenomics (PGx) Product
    Table 91. Illumina, Inc. Revenue in Pharmacogenomics (PGx) Business (2017-2022) & (US$ Million)
    Table 92. Illumina, Inc. Recent Developments
    Table 93. Laboratory Corporation of America Holdings Company Details
    Table 94. Laboratory Corporation of America Holdings Business Overview
    Table 95. Laboratory Corporation of America Holdings Pharmacogenomics (PGx) Product
    Table 96. Laboratory Corporation of America Holdings Revenue in Pharmacogenomics (PGx) Business (2017-2022) & (US$ Million)
    Table 97. Laboratory Corporation of America Holdings Recent Developments
    Table 98. Myriad Genetics, Inc. Company Details
    Table 99. Myriad Genetics, Inc. Business Overview
    Table 100. Myriad Genetics, Inc. Pharmacogenomics (PGx) Product
    Table 101. Myriad Genetics, Inc. Revenue in Pharmacogenomics (PGx) Business (2017-2022) & (US$ Million)
    Table 102. Myriad Genetics, Inc. Recent Developments
    Table 103. Pathway Genomics Company Details
    Table 104. Pathway Genomics Business Overview
    Table 105. Pathway Genomics Pharmacogenomics (PGx) Product
    Table 106. Pathway Genomics Revenue in Pharmacogenomics (PGx) Business (2017-2022) & (US$ Million)
    Table 107. Pathway Genomics Recent Developments
    Table 108. Pfizer, Inc Company Details
    Table 109. Pfizer, Inc Business Overview
    Table 110. Pfizer, Inc Pharmacogenomics (PGx) Product
    Table 111. Pfizer, Inc Revenue in Pharmacogenomics (PGx) Business (2017-2022) & (US$ Million)
    Table 112. Pfizer, Inc Recent Developments
    Table 113. Qiagen, Inc. Company Details
    Table 114. Qiagen, Inc. Business Overview
    Table 115. Qiagen, Inc. Pharmacogenomics (PGx) Product
    Table 116. Qiagen, Inc. Revenue in Pharmacogenomics (PGx) Business (2017-2022) & (US$ Million)
    Table 117. Qiagen, Inc. Recent Developments
    Table 118. Rocheg Company Details
    Table 119. Rocheg Business Overview
    Table 120. Rocheg Pharmacogenomics (PGx) Product
    Table 121. Rocheg Revenue in Pharmacogenomics (PGx) Business (2017-2022) & (US$ Million)
    Table 122. Rocheg Recent Developments
    Table 123. Teva Pharmaceutical Industries Ltd. Company Details
    Table 124. Teva Pharmaceutical Industries Ltd. Business Overview
    Table 125. Teva Pharmaceutical Industries Ltd. Pharmacogenomics (PGx) Product
    Table 126. Teva Pharmaceutical Industries Ltd. Revenue in Pharmacogenomics (PGx) Business (2017-2022) & (US$ Million)
    Table 127. Teva Pharmaceutical Industries Ltd. Recent Developments
    Table 128. Thermo Fisher Scientific Company Details
    Table 129. Thermo Fisher Scientific Business Overview
    Table 130. Thermo Fisher Scientific Pharmacogenomics (PGx) Product
    Table 131. Thermo Fisher Scientific Revenue in Pharmacogenomics (PGx) Business (2017-2022) & (US$ Million)
    Table 132. Thermo Fisher Scientific Recent Developments
    Table 133. Transgenomic, Inc. Company Details
    Table 134. Transgenomic, Inc. Business Overview
    Table 135. Transgenomic, Inc. Pharmacogenomics (PGx) Product
    Table 136. Transgenomic, Inc. Revenue in Pharmacogenomics (PGx) Business (2017-2022) & (US$ Million)
    Table 137. Transgenomic, Inc. Recent Developments
    Table 138. Research Programs/Design for This Report
    Table 139. Key Data Information from Secondary Sources
    Table 140. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Pharmacogenomics (PGx) Market Share by Type: 2021 VS 2028
    Figure 2. Polymerase Chain Reaction (PCR) Features
    Figure 3. Microarray Features
    Figure 4. Sequencing Features
    Figure 5. Other Features
    Figure 6. Global Pharmacogenomics (PGx) Market Share by Application: 2021 VS 2028
    Figure 7. Cardiovascular Diseases (CVD) Case Studies
    Figure 8. Central Nervous System (CNS) Case Studies
    Figure 9. Cancer/Oncology Case Studies
    Figure 10. Infectious Diseases Case Studies
    Figure 11. Other Case Studies
    Figure 12. Pharmacogenomics (PGx) Report Years Considered
    Figure 13. Global Pharmacogenomics (PGx) Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 14. Global Pharmacogenomics (PGx) Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 15. Global Pharmacogenomics (PGx) Market Share by Region: 2021 VS 2028
    Figure 16. Global Pharmacogenomics (PGx) Market Share by Players in 2021
    Figure 17. Global Top Pharmacogenomics (PGx) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmacogenomics (PGx) as of 2021)
    Figure 18. The Top 10 and 5 Players Market Share by Pharmacogenomics (PGx) Revenue in 2021
    Figure 19. North America Pharmacogenomics (PGx) Market Size YoY (2017-2028) & (US$ Million)
    Figure 20. North America Pharmacogenomics (PGx) Market Size Market Share by Type (2017-2028)
    Figure 21. North America Pharmacogenomics (PGx) Market Size Market Share by Application (2017-2028)
    Figure 22. North America Pharmacogenomics (PGx) Market Size Share by Country (2017-2028)
    Figure 23. United States Pharmacogenomics (PGx) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Canada Pharmacogenomics (PGx) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Europe Pharmacogenomics (PGx) Market Size YoY (2017-2028) & (US$ Million)
    Figure 26. Europe Pharmacogenomics (PGx) Market Size Market Share by Type (2017-2028)
    Figure 27. Europe Pharmacogenomics (PGx) Market Size Market Share by Application (2017-2028)
    Figure 28. Europe Pharmacogenomics (PGx) Market Size Share by Country (2017-2028)
    Figure 29. Germany Pharmacogenomics (PGx) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. France Pharmacogenomics (PGx) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. U.K. Pharmacogenomics (PGx) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Italy Pharmacogenomics (PGx) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Russia Pharmacogenomics (PGx) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Nordic Countries Pharmacogenomics (PGx) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Asia-Pacific Pharmacogenomics (PGx) Market Size YoY (2017-2028) & (US$ Million)
    Figure 36. Asia Pacific Pharmacogenomics (PGx) Market Size Market Share by Type (2017-2028)
    Figure 37. Asia Pacific Pharmacogenomics (PGx) Market Size Market Share by Application (2017-2028)
    Figure 38. Asia Pacific Pharmacogenomics (PGx) Market Size Share by Region (2017-2028)
    Figure 39. China Pharmacogenomics (PGx) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Japan Pharmacogenomics (PGx) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. South Korea Pharmacogenomics (PGx) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Southeast Asia Pharmacogenomics (PGx) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. India Pharmacogenomics (PGx) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Australia Pharmacogenomics (PGx) Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 45. Latin America Pharmacogenomics (PGx) Market Size YoY (2017-2028) & (US$ Million)
    Figure 46. Latin America Pharmacogenomics (PGx) Market Size Market Share by Type (2017-2028)
    Figure 47. Latin America Pharmacogenomics (PGx) Market Size Market Share by Application (2017-2028)
    Figure 48. Latin America Pharmacogenomics (PGx) Market Size Share by Country (2017-2028)
    Figure 49. Mexico Pharmacogenomics (PGx) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 50. Brazil Pharmacogenomics (PGx) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 51. Middle East & Africa Pharmacogenomics (PGx) Market Size YoY (2017-2028) & (US$ Million)
    Figure 52. Middle East and Africa Pharmacogenomics (PGx) Market Size Market Share by Type (2017-2028)
    Figure 53. Middle East and Africa Pharmacogenomics (PGx) Market Size Market Share by Application (2017-2028)
    Figure 54. Middle East and Africa Pharmacogenomics (PGx) Market Size Share by Country (2017-2028)
    Figure 55. Turkey Pharmacogenomics (PGx) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 56. Saudi Arabia Pharmacogenomics (PGx) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 57. UAE Pharmacogenomics (PGx) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 58. Abbott Laboratories Revenue Growth Rate in Pharmacogenomics (PGx) Business (2017-2022)
    Figure 59. Affymetrix, Inc. Revenue Growth Rate in Pharmacogenomics (PGx) Business (2017-2022)
    Figure 60. Assurex Health, Inc Revenue Growth Rate in Pharmacogenomics (PGx) Business (2017-2022)
    Figure 61. Astrazeneca Revenue Growth Rate in Pharmacogenomics (PGx) Business (2017-2022)
    Figure 62. GeneDX Revenue Growth Rate in Pharmacogenomics (PGx) Business (2017-2022)
    Figure 63. Illumina, Inc. Revenue Growth Rate in Pharmacogenomics (PGx) Business (2017-2022)
    Figure 64. Laboratory Corporation of America Holdings Revenue Growth Rate in Pharmacogenomics (PGx) Business (2017-2022)
    Figure 65. Myriad Genetics, Inc. Revenue Growth Rate in Pharmacogenomics (PGx) Business (2017-2022)
    Figure 66. Pathway Genomics Revenue Growth Rate in Pharmacogenomics (PGx) Business (2017-2022)
    Figure 67. Pfizer, Inc Revenue Growth Rate in Pharmacogenomics (PGx) Business (2017-2022)
    Figure 68. Qiagen, Inc. Revenue Growth Rate in Pharmacogenomics (PGx) Business (2017-2022)
    Figure 69. Rocheg Revenue Growth Rate in Pharmacogenomics (PGx) Business (2017-2022)
    Figure 70. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Pharmacogenomics (PGx) Business (2017-2022)
    Figure 71. Thermo Fisher Scientific Revenue Growth Rate in Pharmacogenomics (PGx) Business (2017-2022)
    Figure 72. Transgenomic, Inc. Revenue Growth Rate in Pharmacogenomics (PGx) Business (2017-2022)
    Figure 73. Bottom-up and Top-down Approaches for This Report
    Figure 74. Data Triangulation
    Figure 75. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Abbott Laboratories
Affymetrix, Inc.
Assurex Health, Inc
Astrazeneca
GeneDX
Illumina, Inc.
Laboratory Corporation of America Holdings
Myriad Genetics, Inc.
Pathway Genomics
Pfizer, Inc
Qiagen, Inc.
Rocheg
Teva Pharmaceutical Industries Ltd.
Thermo Fisher Scientific
Transgenomic, Inc.
Frequently Asked Questions
Pharmacogenomics (PGx) report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Pharmacogenomics (PGx) report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Pharmacogenomics (PGx) report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Plant Biostimulant

Plant Biostimulant market is segmented by Type and by Application. Players, stakeholders, and oth ... Read More